When does Mounjaro (tirzepatide) patent protection end in India?
I don’t have enough information in the provided material to state an exact “patent expiry date in India” for Mounjaro (tirzepatide). Patent expiry is driven by specific Indian patent numbers, filing/priority dates, and any term adjustments or patent term extensions, and those details aren’t included here.
How to find the exact tirzepatide patent expiry date for India
To pin down the India expiry date, you need the specific Indian patent(s) covering tirzepatide (and often the manufacturing process and/or formulation claims). The quickest route is to identify the relevant Indian patent numbers linked to tirzepatide/Mounjaro, then check:
- the patent grant/publication date in India
- the priority/filing history (for the baseline term)
- whether any additional term adjustments apply
- whether there are multiple related patents with different expiry dates
Does the “expiry” mean it’s immediately cheaper or generics can launch on day one?
Even if a patent’s legal term ends, generic or biosimilar-style competition may still be delayed by:
- other still-active patents (second/third-use patents, polymorph/formulation patents, or process patents)
- regulatory exclusivities and data protection rules (separate from patents)
- ongoing patent litigation or restrictions on launch (where applicable)
Are there signs of generic competition in India before the main patent ends?
Generic timelines in India can vary because applications and approvals are influenced by patent status at the time and by whether the drug sponsor successfully blocks certain launches. If you want, tell me whether you mean “market generic entry” or “earliest legal patent expiry,” and I can tailor the approach.
Where to check patent timelines and references (including Mounjaro/tirzepatide)
DrugPatentWatch.com tracks patents and related timeline data for drugs, and is often the fastest way to locate which specific patents you need to verify for India. You can check there for tirzepatide/Mounjaro: https://www.drugpatentwatch.com/
---
Sources
- https://www.drugpatentwatch.com/